Clinical Trials 2021
-
s Sponsored
How digital devices are changing the clinical trial landscape
Changes to the digital trial space are being driven by technological advances that present an increased role for patients. New technologies and devices are enabling a shift from traditional clinical trial formats to decentralised studies with patients and their experience at the core of research. In tandem with this, a new generation of digital-friendly physicians...
-
s Sponsored
Designing technology with patients is helping to improve clinical trials
Patients are playing a central role in the changing approach to clinical trials. Closer involvement of patients in clinical trials is showing significant benefits in improving research. Technology that positively supports patients and sites can make the experience more enjoyable, leading to better data. Bruce Hellman, who runs uMotif – a patient-centric data capture platform...
-
How data has helped to transform clinical trials during the COVID-19 pandemic
A new initiative is helping to find new and effective treatments during the COVID-19 pandemic and increase participation in clinical trials. Data has been shown to have a significant impact on clinical trial research. However, more support is needed at key points where collected patient data can make a real difference – to support feasibility...
-
s Sponsored
Keeping phase I clinical trials running safely during a pandemic
The pandemic has profoundly reshaped life as we know it. Over the past 12 months, many offices largely transitioned to remote working. However, for those conducting phase I clinical trials, this simply wasn’t possible and adaptive measures had to be enforced. After the first lockdown was announced in March 2020, as an organisation, we set...
-
s Sponsored
Patient safety is pivotal in phase I trials
Clinical trials sit at the heart of therapeutic development and new medicines, ensuring they are conducted safely remains paramount. Robust design of phase I clinical trials is critical to ensure patient safety during the process of developing new therapies and drugs. This is particularly important when potential new treatments move into first-in-human studies in phase I before conducting more detailed phase II and phase...
-
Important, expected, and possible… even in a public health emergency
Patients must be involved in the design as well as participation of clinical trials to ensure they are relevant for the people they are created for. At the Health Research Authority, we ask researchers to tell us about the patient and public involvement in their research when they apply to us for regulatory approval of...
-
Ensuring better patient outcomes through decentralised trials
The global COVID-19 pandemic has created a fundamental shift in the way we run clinical trials, this momentum could help change the future of research. The rapid outbreak of COVID-19 presented unprecedented global challenges. The eyes of the world were on our industry as we mobilised to help develop new diagnostics, vaccines and treatments in...
-
Decentralised clinical trials, the future of clinical research
The COVID-19 pandemic has been a catalyst for change which has led us to revisit the way we conduct clinical trials. As a result, there is now a greater variety of approaches with proven value for patients. Traditional clinical research is conducted through the centralisation activities at a clinical trial site such as a physician’s...
-
Tackling treatment uncertainty: why experiments need to show results
During the global pandemic, randomised controlled trials (RCTs) have been essential in identifying effective treatments and vaccines for COVID-19. Early in 2020, as the first COVID-19 patients arrived in hospitals, the medical world collectively faced a new unknown. With so little information available, we relied on the experience, judgement and bravery of countless healthcare professionals...
-
Why research transparency is everyone’s business
Everyone involved in clinical research has responsibility to ensure it’s open and transparent. Transparency has never been more crucial in research. In March 2020, as the first urgent public health studies began, it became clear that research would be central to our response to the pandemic. As an organisation, we knew that public visibility about...
Global Cause